Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemiaSofie Peirs(Ghent University Hospital), Pieter Van Vlierberghe(Ghent University Hospital)LeukemiaJanuary 11, 201710.1038/leu.2017.10Cited by 69SaveCiteExport RISWatch citationsRelated PapersNovel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies|Scientific Reports|2019|7